Atrial fibrillation: Difference between revisions

(Redirected page to Atrial fibrillation (main))
(Add CHA₂DS₂-VASc calculator (collapsible))
Tag: Reverted
Line 1: Line 1:
#REDIRECT[[Atrial fibrillation (main)]]
#REDIRECT[[Atrial fibrillation (main)]]
<div class="mw-collapsible mw-collapsed" style="border:1px solid #aaa; padding:5px; margin-top:10px;">
<div style="font-weight:bold;">📊 CHA₂DS₂-VASc Calculator [show]</div>
<div class="mw-collapsible-content">
{{CHA2DS2VASc_Calculator}}
</div>
</div>

Revision as of 13:41, 21 March 2026

📊 CHA₂DS₂-VASc Calculator [show]

CHA₂DS₂-VASc Score

CHA₂DS₂-VASc Score Calculator
Criteria No (0) Yes
Congestive heart failure (or LVEF ≤40%) 1 (+1)
Hypertension 1 (+1)
Age ≥75 years 1 (+2)
Diabetes mellitus 1 (+1)
Stroke/TIA/thromboembolism 1 (+2)
Vascular disease (prior MI, PAD, aortic plaque) 1 (+1)
Age 65–74 years 1 (+1)
Sex category (female) 1 (+1)
CHA₂DS₂-VASc Score / 9
Interpretation
0 Low Risk — 0.2% annual stroke risk (males). Anticoagulation generally not recommended.
1 Low-Moderate Risk — 0.6% annual stroke risk (males). Consider anticoagulation (esp. if not due to female sex alone).
≥2 Moderate-High Risk — ≥2.2% annual stroke risk. Oral anticoagulation recommended.
References
  • Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137(2):263-272. PMID 19762550.
  • January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 Guideline for Management of Patients With Atrial Fibrillation. J Am Coll Cardiol. 2019;74(1):104-132. PMID 30703431.